Dextran reduces embolic signals after carotid endarterectomy

Ann Neurol. 2001 Oct;50(4):544-7. doi: 10.1002/ana.1233.

Abstract

One hundred fifty patients undergoing carotid endarterectomy were randomly assigned to receive intravenous 10% dextran 40 or placebo. Transcranial Doppler monitoring of the ipsilateral middle cerebral artery 0 to 1 hour postoperatively detected embolic signals in 57% of placebo and 42% of dextran patients, with overall embolic signal counts 46% less for dextran (p = 0.052). Two to 3 hours postoperatively, embolic signals were present in 45% of placebo and 27% of dextran patients, with embolic signal counts 64% less for dextran (p = 0.040). We conclude that dextran reduces embolic signals within 3 hours of CEA.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anticoagulants / administration & dosage*
  • Carotid Stenosis / surgery
  • Dextrans / administration & dosage*
  • Endarterectomy, Carotid*
  • Female
  • Humans
  • Injections, Intravenous
  • Intracranial Embolism / diagnostic imaging
  • Intracranial Embolism / drug therapy*
  • Intracranial Embolism / prevention & control*
  • Male
  • Middle Aged
  • Postoperative Complications / diagnostic imaging
  • Postoperative Complications / drug therapy
  • Postoperative Complications / prevention & control
  • Ultrasonography, Doppler, Transcranial

Substances

  • Anticoagulants
  • Dextrans